Literature DB >> 6512478

Immunisation practice and policy.

D L Miller.   

Abstract

Immunisation has proved to be a generally safe and effective means of disease control, particularly where environmental approaches are impractical. Recent developments in vaccine production, aimed at selecting or synthesising in pure form the antigens needed to evoke a protective response, give hope of more effective and less toxic vaccines in future. Adequate trials of improved vaccines may, however, be difficult to carry out under modern conditions. Policies for the use of vaccines are sometimes controversial, particularly when there is concern about reactions, as with pertussis vaccine. Acceptance rates for measles and rubella vaccines in the UK have hitherto been disappointingly low and need to be increased if the aims of elimination of measles and congenital rubella are to be achieved. Cost-benefit analyses generally support the use of immunisation in disease control.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6512478      PMCID: PMC1052367          DOI: 10.1136/jech.38.4.265

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  12 in total

1.  Pertussis vaccine--an analysis of benefits, risks and costs.

Authors:  J P Koplan; S C Schoenbaum; M C Weinstein; D W Fraser
Journal:  N Engl J Med       Date:  1979-10-25       Impact factor: 91.245

Review 2.  Whooping cough and whooping cough vaccine: the risks and benefits debate.

Authors:  D L Miller; R Alderslade; E M Ross
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

3.  The case for global measles eradication.

Authors:  D R Hopkins; A R Hinman; J P Koplan; J M Lane
Journal:  Lancet       Date:  1982-06-19       Impact factor: 79.321

4.  Measles in England and Wales--III: Assessing published predictions of the impact of vaccination on incidence.

Authors:  P E Fine; J A Clarkson
Journal:  Int J Epidemiol       Date:  1983-09       Impact factor: 7.196

5.  The benefits from 10 years of measles immunization in the United States.

Authors:  J J Witte; N W Axnick
Journal:  Public Health Rep       Date:  1975 May-Jun       Impact factor: 2.792

Review 6.  Rubella vaccination in the United States: a ten-year review.

Authors:  S R Preblud; M K Serdula; J A Frank; A D Brandling-Bennett; A R Hinman
Journal:  Epidemiol Rev       Date:  1980       Impact factor: 6.222

7.  Current features of measles in the United States: feasibility of measles elimination.

Authors:  A R Hinman; A D Brandling-Bennet; R H Bernier; C D Kirby; D L Eddins
Journal:  Epidemiol Rev       Date:  1980       Impact factor: 6.222

8.  Rational strategy for rubella vaccination.

Authors:  A R Hinman; K J Bart; W A Orenstein; S R Preblud
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

Review 9.  Vaccinology of poliomyelitis.

Authors:  D Salk; J Salk
Journal:  Vaccine       Date:  1984-03       Impact factor: 3.641

10.  Pertussis immunisation and serious acute neurological illness in children.

Authors:  D L Miller; E M Ross; R Alderslade; M H Bellman; N S Rawson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.